Pharmafile Logo

#RemoteDetailing

AstraZeneca AZ

AZ’s comeback drug cediranib stumbles in phase 3 trial

Failed to improve on platinum-based chemotherapy

- PMLiVE

Evoke KYNE appoints global head of digital

Julie O'Donnell will also take on the role of executive vice president

- PMLiVE

Pegasus gains a new managing director and digital lead

Corrina Safeio and Jon Buckley join the team

- PMLiVE

Lucid Group Elevates its Editorial Centre of Excellence – COMET

Lucid Group has been busy expanding and operationalising its editorial team – COMET (Centre Of Medical EdiTing) – to ensure its successful integration into Lucid Group. This has been achieved...

Lucid Group Communications Limited

- PMLiVE

Mapping the patient journey and minding the gap

Seven steps to closing the gap between rhetoric and reality in patient-centricity

- PMLiVE

Golin appoints new group managing director

Ondine Whittington now group managing director of Golin and Virgo Health

- PMLiVE

Gilead drug reduces HIV viral reservoir, says researcher

Treatment with drug was associated with longer viral suppression

- PMLiVE

Genmab hires first chief operating officer

Anthony Mancini joins from Bristol-Myers Squibb

- PMLiVE

Gates Foundation, Wellcome launch fast-track COVID-19 therapy fund

Partners commit $125m to seed-fund for potential treatments

- PMLiVE

NHS increases COVID-19 testing capacity, FDA halts foreign inspections

New measures to tackle the novel coronavirus announced across the Atlantic

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links